iStock_17000305_XXXLARGE.jpg

ABOUT OUR COMPANY

Get to know our company 

About Biocelect

Biocelect is actively involved in the sourcing, in-licencing, and the commercialisation of pharmaceutical and in vitro diagnostic products for the Australian, New Zealand and Pacific region. We aim to contribute to meeting the medical needs of patients in the region.

 

Biocelect is a growing business now having successfully had a range of products approved through the TGA (Therapeutic Goods Administration) and MedSafe New Zealand. These include two travel medicines, an intravenous influenza antiviral and a novel diagnostic. Biocelect has other products being evaluated that it hopes to be able to add to its growing portfolio over 2021 and 2022.

 

Being an agile company, we can provide a range of bespoke partnering solutions for companies wanting to provide their products in the region for patients to access. Biocelect has an experienced and seasoned team with the ability to draw on the experience of its companion company, Biointelect, www.biointelect.com and Biointelect's cross functional expertise and experienced biopharmaceutical and MedTech industry staff. This allows Biocelect the ability to provide the functionality of a bigger company to partners and ensuring the success of their product. With the aim of meeting the medical needs of the patient.

Biocelect Logo_Colour.png

Copyright 2019 Biocelect 

Australian Office: Suite 502, 139 Macquarie Street, Sydney NSW 2000, Australia

Registered Office Australia: Suite 405, Level 4, 51 Rawson Street, Epping NSW, 2121,  Australia 

Registered Office New Zealand: Level 5, Wynn Williams House, 47 Hereford Street, Christchurch 8013, New Zealand

Biocelect acknowledges the Traditional Custodians of Australia and their continued connection to land,

sea and community. We pay our respects to the Elders, past and present. 

Privacy Policy

  • LinkedIn Social Icon